What's breaking now, across thousands of outlets.
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
We haven't written up this one. Channel News Asia has the full story — the link below goes straight to it.
(RTTNews) - Aurinia Pharmaceuticals Inc. (AUP.V) revealed earnings for third quarter of $31.70 million
Kenya expects to complete the release of people under Ebola quarantine and surveillance by November 11, following 10 days without reporting a new infection.
Hundreds of practices hit by small health tech firm going into administration
Using a proof-of-concept test to analyze fragments of RNA in urine, researchers can detect cases of bladder cancer.
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and…
The B.C. NDP government made cuts to the care provided by the B.C. Centre for Long COVID, ME/CFS & Fibromyalgia two days before calling a snap election
